Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implantable, wireless brain-computer interface. The trial aims to evaluate the safety of its N1 Implant and R1 surgical robot, while testing the ability of the BCI system to help individuals with quadriplegia control external devices like computers and …
